| Financial Year |
March 31 2023 |
| Monetary Funds |
9,466,512,202.06 |
| Held-for-trading Financial Assets |
1,017,449,760.31 |
| Notes Receivable |
4,109,802.47 |
| Accounts Receivable |
1,507,243,939.14 |
| Advances to Suppliers |
473,543,268.76 |
| Other Receivables |
343,068,437.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
11,687,365.92 |
| Dividend Receivable |
-- |
| Inventories |
1,869,637,051.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
104,490,462.55 |
| Other Current Assets |
6,080,427,100.43 |
| Total Current Assets |
20,866,482,024.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
123,178,657.95 |
| Long-term Equity Investment |
203,450,684.38 |
| Investment Properties |
88,924,630.04 |
| Fixed Assetes |
1,343,606,644.75 |
| Under-construction Projects |
505,447,805.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
969,436,369.67 |
| R&D expenses |
-- |
| Goodwill |
62,385,078.58 |
| Long-Term Deferred and Prepaid Expenses |
93,427,632.27 |
| Deferred Income Tax Assets |
26,181,235.92 |
| Other Non-Current Assets |
77,262,594.45 |
| Sub-Total of Non-Current Assets |
3,811,301,443.40 |
| Total Assets |
24,677,783,467.80 |
| Short-Term Loans |
276,142,464.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
128,600,000.00 |
| Accounts Payable |
3,530,009,268.42 |
| Accounts Received In Advance |
15,991,867.02 |
| Employee Compensation Payable |
460,023,442.54 |
| Taxes Payable |
37,744,785.25 |
| Interest Payable |
-- |
| Dividend Payable |
20,152,286.15 |
| Other payables |
412,130,614.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,150,494.86 |
| Other Current Liabilities |
285,122,915.30 |
| Sub-Total of Current Liabilities |
8,142,871,976.96 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
517,655,400.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
33,623,042.26 |
| Sub-Total of Non-Current Liabilities |
732,956,768.47 |
| Total Liabilities |
8,875,828,745.43 |
| Paid-In Capital(Or Share Stock) |
1,796,000,000.00 |
| Capital Surplus |
4,449,897,553.75 |
| Surplus Reserve |
1,420,713,554.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,183,030,596.78 |
| Minority Stockholder's Interest |
811,687,458.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,990,267,263.74 |
| Owner's Equity（Stockholder's Equity） |
15,801,954,722.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,677,783,467.80 |
